Does OFATUMUMAB Cause Malignant neoplasm progression? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Malignant neoplasm progression have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.2% of all adverse event reports for OFATUMUMAB.
61
Reports of Malignant neoplasm progression with OFATUMUMAB
0.2%
of all OFATUMUMAB reports
29
Deaths
20
Hospitalizations
How Dangerous Is Malignant neoplasm progression From OFATUMUMAB?
Of the 61 reports, 29 (47.5%) resulted in death, 20 (32.8%) required hospitalization, and 5 (8.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which OFATUMUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB